title: PO-56 - Subsequent clot properties depend on the storage time of platelet concentrates.
abstract: BACKGROUND
  Despite platelets properties varies during storage, transfused platelets are included in blood clot in the same way as well as native. We assume that after transfusion the prevalence of platelets with changed activity lead to worse quality of blood clot in vivo.
  
  
  OBJECTIVE
  The aim was the in vitro study of platelet-dependent clot properties that are formed from some stored platelet concentrates (PCs).
  
  
  METHODS
  Twenty-six PCs in autologous plasma and 24 PCs in platelet additive solution SSP+ (MacoPharma, France) (70vol.%) were analized by thromboelastography with and without platelets activation, and by standard aggregometry. The testing were carried out at the day of proceeding, after 24 hours, and at 3rd and 5th days of storage. We used Trima Accel (Terumo BCT, USA) for the proceeding of platelets apheresis.
  
  
  RESULTS
  We found that clot demonstrated gradual reduction of elasticity and deformability starting from second day to fifth day in stored PCs suspended in autologous plasma. From the third storage day platelets lost their meaning for clot properties. The platelets apheresis with next re-suspending in SSP+ solution leads to the depression for platelets aggregability. Actived platelets had no impact to clot properties during full storage time. Total decline of clot quality including low elasticity and impaired deformability were found starting from 3rd storage day compared to the day of proceeding.
  
  
  CONCLUSIONS
  We assume that such properties of clot as both elasticity and deformability are forming in PCs at the day of proceeding. Further clot changes observed in PCs does not depend directly from platelets aggregability because clot forming are under other influences. The last are determined mainly by the coagulation what was no included in this study. Also obtained results confirms the 5th-days storage as a benefit independent from PCs proceeding method.
authors.affiliation: Federal Scientific and Clinical Centre on Pediatric Hematology, Oncology and Immunology n.a.D.Rogachev; Pirogov Russian National Research Medical University.
authors.forename: I M
authors.initials: IM
authors.lastname: Kolesnikova
authors.affiliation: Pirogov Russian National Research Medical University.
authors.forename: E V
authors.initials: EV
authors.lastname: Roitman
authors.affiliation: Federal Scientific and Clinical Centre on Pediatric Hematology, Oncology and Immunology n.a.D.Rogachev; City Clinical Hospital; Moscow, Russia.
authors.forename: O V
authors.initials: OV
authors.lastname: Karpova
authors.affiliation: Federal Scientific and Clinical Centre on Pediatric Hematology, Oncology and Immunology n.a.D.Rogachev; Pirogov Russian National Research Medical University.
authors.forename: S A
authors.initials: SA
authors.lastname: Roumiantsev